CymaBay Therapeutics cymabay.com


Public list: BIO 2016 (619) Pharma Startups (4740) Rare Diseases (230)

CymaBay Therapeutics, formerly Metabolex, is a privately-held biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, with an emphasis on type 2 diabetes. The company has drawn on its deep understanding of diabetes to create a large database of genes involved in diabetes and to build a rich pipeline of product candidates and drug discovery targets. The company has four clinical-stage compounds: MBX-102/JNJ 39659100,...Show all

CymaBay Therapeutics, formerly Metabolex, is a privately-held biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, with an emphasis on type 2 diabetes. The company ha...Show all

Company (IPO / Went public)

Phone: 510-293-8800

Fax:

7999 Gateway Blvd.
Suite 130
Newark, 94560
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CymaBay Therapeutics $203.3M Jul 28, 2014
See all 27 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CymaBay Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Alta PartnersVenture CapitalSan Francisco, California, United StatesSeries E, Unattributed VC - II, Series D, Series C, Series B - III, Series B - II, Series B, Series A - II, Series A
Bay City CapitalVenture CapitalSan Francisco, California, United StatesSeries E, Unattributed VC - II, Series D, Series C, Unattributed VC, Series A - II, Series A
AllianceBernsteinAsset/Investment ManagementNew York, New York, United StatesSeries D, Series A
AbbottCorporationAbbott Park, Illinois, United StatesOther Investors
Biotechnology Turnaround FundNetherlandsUnattributed VC - II, Series D, Unattributed VC, Other Investors
See all 36 investors

Competitors

Company Status Description Investors
See all 27 competitors